School of Pharmacy

Tom Hazlet

Associate Professor, Department of Pharmacy; Adjunct Associate Professor, UW Department of Health Services, School of Public Health & Community Medicine and School of Law; Director, Master of Science in Biomedical Regulatory Affairs Program

CHOICE Faculty, Department of Pharmacy, Pharmacy Faculty

Telephone: (206) 616-2732


Office Location: H375-S Box 357630 1959 NE Pacific St Seattle, WA 98195-7630


  • DrPH in Health Policy & Administration, University of California, Berkeley
  • PharmD, University of California, San Francisco
  • Bachelor of Science in Biology, University of Redlands

Research Interests

  • Drug regulation
  • Pharmaceutical policy
  • Bioethics

Courses Taught

  • Pharm 516-18:Certificate Program in Biomedical Regulatory Affairs
  • Pharm 523: Survey of Biomedical Regulatory Affairs
  • Pharm 532: Methods in Pharmaceutical Policy Analysis
  • Pharm 543: Pharmacy Law & Ethics
  • Pharm 597: Graduate Seminar


Dr. Hazlet’s prior experience includes industrial microbiology with Baxter Healthcare Corporation, parenteral nutrition at UCLA, pharmacy practice in a community hospital, and regulatory experience with California Department of Health Services’ Food and Drug Branch and a member of the U.S. Food and Drug Administration’s Pacific Region Biotechnology Team. His research interests include assessment of the consequences of pharmaceuticals policy change and have included an evaluation of reference pricing in British Columbia’s Pharmacare pharmaceutical benefit, 3-tier copayment programs with Washington health insurers, and various technologies for vaccine delivery in global health. He is an associate professor with UW’s Pharmaceutical Outcomes Research and Policy Program. He directs the UW professional master of science degree in Biomedical Regulatory Affairs.

He has served on the UW Faculty Senate, Graduate School Council and Faculty Senate Adjudication Committee. He has also been a dissertation committee member for graduate students. His interests are in policy assessment and the impact of health policy on patient outcomes. Recent projects have included an assessment of developing countries application of measles vaccines, insurance coverage for gastrointestinal disease drugs in British Columbia’s Pharmacare program and a comparison of insurance coverage for drugs in Washington.